Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.
Da Gama Duarte J, Parakh S, Andrews MC, Woods K, Pasam A, Tutuka C, Ostrouska S, Blackburn JM, Behren A, Cebon J. Da Gama Duarte J, et al. Front Immunol. 2018 Mar 2;9:411. doi: 10.3389/fimmu.2018.00411. eCollection 2018. Front Immunol. 2018. PMID: 29552014 Free PMC article. Clinical Trial.
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.
Klein O, Kee D, Gao B, Markman B, da Gama Duarte J, Quigley L, Jackett L, Linklater R, Strickland A, Scott C, Mileshkin L, Palmer J, Carlino M, Behren A, Cebon J. Klein O, et al. Among authors: da gama duarte j. J Immunother Cancer. 2021 Nov;9(11):e003156. doi: 10.1136/jitc-2021-003156. J Immunother Cancer. 2021. PMID: 34782426 Free PMC article. Clinical Trial.
B cells and antibody production in melanoma.
Da Gama Duarte J, Peyper JM, Blackburn JM. Da Gama Duarte J, et al. Mamm Genome. 2018 Dec;29(11-12):790-805. doi: 10.1007/s00335-018-9778-z. Epub 2018 Sep 3. Mamm Genome. 2018. PMID: 30178304 Review.
Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.
Mooi J, Chionh F, Savas P, Da Gama Duarte J, Chong G, Brown S, Wong R, Price TJ, Wann A, Skrinos E, Mariadason JM, Tebbutt NC. Mooi J, et al. Among authors: da gama duarte j. Clin Cancer Res. 2021 Apr 15;27(8):2159-2167. doi: 10.1158/1078-0432.CCR-20-2714. Epub 2021 Jan 29. Clin Cancer Res. 2021. PMID: 33514526 Clinical Trial.